Thibault Joseph William Jacques Dit Lapierre

6PUBLICATIONS
23CO-AUTHORS
Basic pharmacologyNanotoxicology, health and safetyMolecular medicineCheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 29, 2025
Hit-to-Lead Studies of Pyrazinylpiperazines against Visceral Leishmaniasis: Pharmacokinetic Profile and In Vivo Efficacy of Potent Compounds against Leishmania infantum.

Thibault Joseph William Jacques Dit Lapierre, Mariza Gabriela Faleiro de Moura Lodi Cruz, Gisele Barbosa

|Jul 06, 2024
Modulation of the Meisenheimer complex metabolism of nitro-benzothiazinones by targeted C-6 substitution.

François Keiff, Freddy A Bernal, Melanie Joch

|May 08, 2024
New drug discovery strategies for the treatment of benznidazole-resistance in Trypanosoma cruzi, the causative agent of Chagas disease.

Silvane Maria Fonseca Murta, Pedro Augusto Lemos Santana, Thibault Joseph William Jacques Dit Lapierre

|Sep 29, 2023
Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.

Mariana Laureano de Souza, Thibault Joseph William Jacques Dit Lapierre, Gabriel Vitor de Lima Marques

|Sep 05, 2023
Design and synthesis of benzofuran- and naphthalene-fused thiazinones as antimycobacterial agents.

François Keiff, Thibault J W Jacques Dit Lapierre, Freddy A Bernal

Pageof 1